Evogenom, based in Finland, offers a unique wellness solution by combining DNA analysis with an AI wellness coach called EvoCoach. This approach moves beyond traditional wellness methods based on averages, providing a highly personalized and science-backed framework. The company stands out by integrating DNA data, empathetic AI, and individual lifestyle habits to create a tailored wellness plan focusing on aspects such as sleep, energy, weight, exercise, and perimenopause.
The innovative platform is poised to redefine consumer genetics and wellness industries by offering tangible, lasting results. While specific founding details and investment history remain undisclosed, Evogenom is actively seeking partners and investors to expand its influence. Under the guidance of CEO Sofia Lund, the company invites collaboration and investment to advance its mission of personalized wellness.